Yttrium-90 radioembolization in the management of liver tumors: Expanding the global experience

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 37, Issue 3, 2010, Pages 451-452

  Riaz, Ahsun ^a   Salem, Riad ^a,b  

^a NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; MICROSPHERE; RESIN; SIR-SPHERES; THERASPHERE; UNCLASSIFIED DRUG; YTTRIUM 90;

ARTIFICIAL EMBOLISM; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; COLORECTAL CARCINOMA; DOSIMETRY; DRUG FORMULATION; HUMAN; LIVER CANCER; LIVER CELL CARCINOMA; NOTE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIOEMBOLIZATION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT OUTCOME; TREATMENT RESPONSE;

CARCINOMA, HEPATOCELLULAR; EMBOLIZATION, THERAPEUTIC; HUMANS; INTERNATIONALITY; LIVER NEOPLASMS; YTTRIUM RADIOISOTOPES;

EID: 77949261497     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-009-1345-0     Document Type: Note

References (10)

1. DM Parkin F Bray J Ferlay P Pisani 2005 Global cancer statistics, 2002 CA Cancer J Clin 55 74 108 10.3322/canjclin.55.2.74 15761078
2. JM Llovet S Ricci V Mazzaferro P Hilgard E Gane JF Blanc, et al. 2008 Sorafenib in advanced hepatocellular carcinoma N Engl J Med 359 378 390 10.1056/NEJMoa0708857 1:CAS:528:DC%2BD1cXovFWjsL8%3D 18650514
3. V Mazzaferro E Regalia R Doci S Andreola A Pulvirenti F Bozzetti, et al. 1996 Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 693 699 10.1056/NEJM199603143341104 1:STN:280:DyaK287nsFWltw%3D%3D 8594428 (Pubitemid 26079803)
4. DR Carpizo M D'Angelica 2009 Liver resection for metastatic colorectal cancer in the presence of extrahepatic disease Lancet Oncol 10 801 809 10.1016/S1470-2045(09)70081-6 19647200
5. GB Stillwagon SE Order C Guse JL Klein PK Leichner SA Leibel, et al. 1989 194 hepatocellular cancers treated by radiation and chemotherapy combinations: toxicity and response: a Radiation Therapy Oncology Group Study Int J Radiat Oncol Biol Phys 17 1223 1229 1:STN:280:DyaK3c%2Fptl2jtw%3D%3D 2557307
6. LA Dawson D Normolle JM Balter CJ McGinn TS Lawrence RK Ten Haken 2002 Analysis of radiation-induced liver disease using the Lyman NTCP model Int J Radiat Oncol Biol Phys. 53 810 821 12095546
7. Salem R, Lewandowski RJ, Mulcahy MF, Riaz A, Ryu RK, Ibrahim S, et al. Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes. Gastroenterology. 2009.
8. A Riaz RJ Lewandowski LM Kulik MF Mulcahy KT Sato RK Ryu, et al. 2009 Complications following radioembolization with yttrium-90 microspheres: a comprehensive literature review J Vasc Interv Radiol. 20 1121 1130 10.1016/j.jvir.2009.05.030 19640737 quiz 31
9. Garin E, Rolland Y, Boucher E, Ardisson V, Laffont S, Boudjema K, et al. First experience of hepatic radioembolization using microspheres labelled with yttrium-90 (TheraSphere): practical aspects concerning its implementation. Eur J Nucl Med Mol Imaging. 2009. doi: 10.1007/s00259-009-1279-6.
10. A Riaz RK Ryu LM Kulik MF Mulcahy RJ Lewandowski J Minocha, et al. 2009 Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma: oncologic marker of radiologic response, progression, and survival J Clin Oncol 27 5734 5742 10.1200/JCO.2009.23.1282 1:CAS:528:DC%2BC3cXhtVWisbs%3D 19805671